Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000680

Drug Information
NameMethylphenobarbital
SynonymsMephobarbitone; 5-Ethyl-1-methyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione; 5-ethyl-1-methyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione; 5-ethyl-1-methyl-5-phenyl-1,3-diazinane-2,4,6-trione; N-Methylethylphenylbarbituric acid; Mebroin; Metylfenemal; Mebaral; Methyl-calminal; AKOS002254670; 115-38-8; Mephobarbital (JAN/USP); Enphenemalum; N-Methyl-5-phenyl-5-ethylbarbital; Phemetone; C07829; 5-Ethyl-1-methyl-5-phenylbarbituric acid; Metyna; ALARQZQTBTVLJV-UHFFFAOYSA-; Methyl phenobarbitone; Methylphenylbarbituric acid; NCGC00159357-02; AC-16075; Prominaletten; 1-Methylphenobarbital; InChI=1/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18); Metilfenobarbital [INN-Spanish]; N-Methylphenobarbital; AC1L1QMW; BRN 0256144; Meberal; CHEBI:6758; Isonal (roussel); Metilfenobarbitale [DCIT]; NCGC00159357-03; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1-methyl-5-phenyl-; Methylphenobarbital (INN); Methylphenobarbitonum; 5-Ethyl-N-methyl-5-phenylbarbituric acid; Phemiton; 1-Methyl-5-phenyl-5-ethylbarbituric acid; Sanofi Brand of Mephobarbital; N-Ethylmethylphenylbarbituric acid; Metilfenobarbitale; Sanofi Synthelabo Brand of Mephobarbital; DB00849; Mephobarbital [JAN]; D00700; 5-Phenyl-5-ethyl-3-methylbarbituric acid; Methylphenobarbitalum; MolPort-000-839-979; STK732046; Methylphenobarbitone; Phemitone; Prominalum; Methylphenolbarbital; Mephobarbital; Mephytal; Oprea1_133475; LS-24423; Enfenemal; D008618; EINECS 204-085-7; MolPort-002-537-654; Phenmiton; CID8271; Methylphenobarbitalum [INN-Latin]; Metilfenobarbital; Barbituric acid, 5-ethyl-1-methyl-5-phenyl-; 1-Methyl-5-ethyl-5-phenylbarbituric acid; Enphenemal; CHEMBL45029; Menta-Bal; N-Methylphenolbarbitol; Morbusan; 5-24-09-00294 (Beilstein Handbook Reference); UNII-5NC67NU76B; DEA No. 2250; Prominal; METHYLPHENOBARBITAL; HSDB 3579; Bio-0356; Mebaral (TN); 5-Ethyl-5-phenyl-N-methyl-bartituric acid
Trade NameMebaral
CompanyOvation Pharmaceuticals
IndicationAnxiety disorder
[ICD9: 300   ICD10: F40-F42]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/
h4-8H,3H2,1-2H3,(H,14,16,18)
InChIKeyALARQZQTBTVLJV-UHFFFAOYSA-N
Canonical SMILESCCC1(C(=O)NC(=O)N(C1=O)C)C2=CC=CC=C2    
Therapeutic ClassHypnotics and Sedatives
CAS NumberCAS 115-38-8
FormulaC13H14N2O3
PubChem Compound IDCID 8271.
PubChem Substance IDSID 10031.
ChEBI6758;
SuperDrug ATC IDN03AA01
SuperDrug CAS ID000115388;
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3]
Ref 1Drug information of Methylphenobarbital, 2008 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543